cbdMD, Inc. financials

YCBD CIK 0001644903

Source: EDGAR filings · Built 2026-06-19T03:25:34Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow -1.64M -542.81K -4.60M -15.66M -14.44M -11.98M
EBITDA -1.04M -2.17M -20.69M -76.43M -18.60M -16.86M
Working Capital 3.36M -2.23M 3.40M 10.73M 29.59M 16.02M
Net Debt -1.48M -1.18M 2.17M -2.62M -20.23M -7.34M
Gross Margin 62.37% 61.57% 62.01% 63.09% 67.41% 62.96%
Operating Margin -11.27% -17.02% -93.10% -221.07% -44.10% -41.98%
Net Margin -10.63% -18.99% -94.96% -197.96% -52.60% 30.09%
Return on Equity (ROE) -28.24% -188.45% -253.99% -223.02% -22.68% 15.92%
Return on Assets (ROA) -19.59% -34.97% -141.64% -171.81% -18.73% 11.37%
Current Ratio 2.05× 0.74× 1.73× 3.03× 5.28× 3.08×
Debt-to-Equity 0.11× 0.65× 0.44× 0.13× 0.06× 0.09×
Effective Tax Rate 0.00% 0.00% 0.00% 0.00% 3.68% 11.90%
Cash Conversion Ratio 0.71× 0.10× 0.19× 0.21× 0.60× -0.85×
Accruals Ratio -0.06× -0.32× -1.15× -1.35× -0.07× 0.21×
SBC % of Revenue 2.92% 4.54%
CapEx Coverage -7.89× -1.86× -14.46× -21.73× -41.21× -8.08×
Free Cash Flow Per Share $-0.41 $-1.01 $-2.27 $-11.79 $-0.26 $-0.27

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 19.19M 19.48M 24.16M 35.40M 44.48M 41.88M
Cost of Revenue 7.22M 7.49M 9.18M 13.07M 14.50M 15.51M
Gross Profit 11.97M 12.00M 14.98M 22.34M 29.99M 26.37M
Operating Expenses 49.60M 43.95M
Operating Income (Loss) -2.16M -3.32M -22.49M -78.27M -19.62M -17.58M
Income Tax Expense (Benefit) 0 0 0 0 -895.00K 1.35M
Net Income (Loss) Attributable to Parent -2.04M -3.70M -22.94M -70.08M -23.39M 12.60M
Earnings Per Share, Basic $-1.09 $-14.29 $-13.32 $-55.80 $-0.47 $0.28
Weighted Average Number of Shares Outstanding, Basic 4.02M 539,069 2.02M 1.33M 54.94M 44.14M
Earnings Per Share, Diluted $-1.09 $-14.29 $-13.32 $-55.80 $-0.47 $0.28
Weighted Average Number of Shares Outstanding, Diluted 4.02M 539,069 2.02M 1.33M 54.94M 45.17M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 2.26M 2.45M 1.80M 6.72M 26.41M 14.82M
Assets, Current 6.55M 6.39M 8.07M 16.01M 36.50M 23.71M
Assets 10.42M 10.58M 16.20M 40.79M 124.88M 110.84M
Liabilities, Current 3.19M 8.62M 4.67M 5.29M 6.92M 7.69M
Long-term Debt, Excluding Current Maturities 9 125.49K 108.98K 264.37K
Liabilities 3.19M 8.62M 7.16M 9.37M 21.74M 31.66M
Stockholders' Equity Attributable to Parent 7.23M 1.96M 9.03M 31.42M 103.14M 79.18M
Common Stock, Shares, Outstanding 8.92M 492,383 2.96M 1.35M 57.78M 52.13M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities -1.45M -352.79K -4.30M -14.97M -14.09M -10.66M
Payments to Acquire Property, Plant, and Equipment 184.17K 190.01K 297.55K 688.68K 342.01K
Net Cash Provided by (Used in) Investing Activities -184.17K -290.01K 702.45K -688.68K -2.55M -1.57M
Payments of Dividends 2.55M 366.85K
Net Cash Provided by (Used in) Financing Activities 1.45M 1.30M -1.32M -4.04M 28.23M 22.37M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (YCBD CIK 0001644903), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

MRNA

Moderna, Inc.

USBC

USBC, INC.

DD

DUPONT DE NEMOURS, INC.